ATE511395T1 - Mittel zur behandlung von glomerulopathie - Google Patents

Mittel zur behandlung von glomerulopathie

Info

Publication number
ATE511395T1
ATE511395T1 AT02720493T AT02720493T ATE511395T1 AT E511395 T1 ATE511395 T1 AT E511395T1 AT 02720493 T AT02720493 T AT 02720493T AT 02720493 T AT02720493 T AT 02720493T AT E511395 T1 ATE511395 T1 AT E511395T1
Authority
AT
Austria
Prior art keywords
glomerular
glomerulopathy
agents
treatment
preventive
Prior art date
Application number
AT02720493T
Other languages
English (en)
Inventor
Takashi Nakagawa
Makoto Suda
Yoichi Yamauchi
Original Assignee
Kowa Co
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co, Nissan Chemical Ind Ltd filed Critical Kowa Co
Application granted granted Critical
Publication of ATE511395T1 publication Critical patent/ATE511395T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02720493T 2001-04-19 2002-04-18 Mittel zur behandlung von glomerulopathie ATE511395T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001121058 2001-04-19
JP2001361257 2001-11-27
PCT/JP2002/003870 WO2002085363A1 (fr) 2001-04-19 2002-04-18 Agent therapeutique pour soigner la maladie glomerulaire

Publications (1)

Publication Number Publication Date
ATE511395T1 true ATE511395T1 (de) 2011-06-15

Family

ID=26613829

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02720493T ATE511395T1 (de) 2001-04-19 2002-04-18 Mittel zur behandlung von glomerulopathie

Country Status (6)

Country Link
US (1) US7504415B2 (de)
EP (1) EP1386608B1 (de)
JP (1) JP4235000B2 (de)
AT (1) ATE511395T1 (de)
PT (1) PT1386608E (de)
WO (1) WO2002085363A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4235000B2 (ja) 2001-04-19 2009-03-04 興和株式会社 糸球体疾患治療剤
MY131170A (en) * 2002-03-28 2007-07-31 Nissan Chemical Ind Ltd Therapeutic agent for glomerular disease
EP1806137A4 (de) * 2004-10-29 2011-03-30 Kowa Co Therapeutischer wirkstoff zur behandlung von glomerulärer erkrankung
WO2008082537A2 (en) 2006-12-19 2008-07-10 The General Hospital Corporation Compounds for modulating integrin cd11b/cd18
WO2013159082A1 (en) 2012-04-20 2013-10-24 Adhaere Pharmaceuticals, Inc. Compounds and methods for regulating integrins

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2569746B2 (ja) 1987-08-20 1997-01-08 日産化学工業株式会社 キノリン系メバロノラクトン類
CA1336714C (en) * 1987-08-20 1995-08-15 Yoshihiro Fujikawa Quinoline type mevalonolactone inhibitors of cholesterol biosynthesis
CA2052014A1 (en) * 1990-10-19 1992-04-20 Henry Y. Pan Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor
JPH08198898A (ja) 1995-01-30 1996-08-06 Takeda Chem Ind Ltd コレステロール搬出促進物質
US6090839A (en) * 1996-12-23 2000-07-18 Merck & Co., Inc. Antidiabetic agents
US6147109A (en) 1997-10-14 2000-11-14 The General Hospital Corporation Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors
CN1651087A (zh) * 2000-04-12 2005-08-10 诺瓦提斯公司 有机化合物的联合形式
US6620821B2 (en) * 2000-06-15 2003-09-16 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method
CA2420844A1 (en) 2000-08-30 2003-02-28 Sankyo Company, Limited Medicinal compositions for preventing or treating heart failure
CN1230173C (zh) 2000-10-12 2005-12-07 日产化学工业株式会社 糖尿病合并症预防及治疗剂
JP4235000B2 (ja) 2001-04-19 2009-03-04 興和株式会社 糸球体疾患治療剤

Also Published As

Publication number Publication date
WO2002085363A1 (fr) 2002-10-31
US20040116468A1 (en) 2004-06-17
EP1386608A4 (de) 2005-02-09
EP1386608A1 (de) 2004-02-04
EP1386608B1 (de) 2011-06-01
PT1386608E (pt) 2011-07-26
JPWO2002085363A1 (ja) 2004-08-05
JP4235000B2 (ja) 2009-03-04
US7504415B2 (en) 2009-03-17

Similar Documents

Publication Publication Date Title
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
CY1111951T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
EA200201247A1 (ru) Соединения для лечения болезни альцгеймера
CY1110969T1 (el) 5-υποκατεστημενα-2-φαινυλαμινο-βενζαμιδια ως αναστολεiς μεκ
ATE272398T1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
EA200401114A2 (ru) Замещённые гидроксиэтиламины
ATE103808T1 (de) N-(3,4-dimethoxycinnamoyl)-anthranilsaeure enthaltende arzneimittelzusammensetzungen.
DE502004006619D1 (de) Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson
DK1458393T3 (da) Substituerede diketopiperaziner som oxytocinantagonister
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
ATE550039T1 (de) Mittel zur behandlung von glomerulären erkrankungen
DE60002558D1 (de) Derivate der Phosphonsäure zur Inhibierung von Carboxypeptidase B
ATE511395T1 (de) Mittel zur behandlung von glomerulopathie
IL150965A0 (en) Therapeutic or preventive agent for digestive system diseases containing a diaminotrifluoromethylpyridine derivative
ATE332697T1 (de) Cyanidinmischung zur behandlung von dickdarmkrebs
DK1174131T3 (da) Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom
NO20015666D0 (no) Umiddelbar frigivelses medisinske sammensetninger for oral anvendelse
ATE305783T1 (de) Verwendung von diaminotrifluoromethylpyridinderivaten für die prevention und behandlung von lebererkrankungen
BR0214780A (pt) Sal de ácido cìtrico de um composto terapêutico e composições farmacêuticas deste
DE60143671D1 (de) Behandlung von neuropathischen schmerzen mittels eines n-methyl-d-aspartate (nmda)-rezeptor-antagonists
ATE359778T1 (de) Mittel zur behandlung von myelopathie
TH51180A (th) วิธีสำหรับการรักษาโรคพาร์คินสันโดยการให้ (-)-5- คีโท-2-N,N-ได-n-โปรพิลอะมิโน-เตตระไฮโดรเตตระลิน
DE60034580D1 (de) Peptid zur behandlung von nervenerkrankungen
TH62460A (th) ตัวยับยั้งเมทัลโลโพรทีเอสที่ได้รับการแทนที่ที่ n ซึ่งมีโซ่ข้างเฮเทอโรไซคลิค

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties